rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2010-9-10
|
pubmed:abstractText |
The suboptimal sensitivity of Interferon (IFN)-?-based in-vitro assays, especially in immunocompromised individuals, emphasizes the need for alternative markers for diagnosing tuberculosis (TB). The objective of this study was to evaluate whether interferon-inducible protein (IP)-10, monocyte chemotactic protein (MCP)-2 and interleukin (IL)-2 can be useful biomarkers for evaluating a specific response to RD1 antigens associated to active TB disease in HIV-infected individuals.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1932-6203
|
pubmed:author |
pubmed-author:AlameluRajaR,
pubmed-author:CarraraStefaniaS,
pubmed-author:GirardiEnricoE,
pubmed-author:GolettiDeliaD,
pubmed-author:IppolitoGiuseppeG,
pubmed-author:LagrangePhilippe HenriPH,
pubmed-author:LeportierMarcM,
pubmed-author:LonguetChristopheC,
pubmed-author:RodriguesCamillaC,
pubmed-author:SodhaArchanaA,
pubmed-author:Syed Ahamed KabeerBasirudeenB,
pubmed-author:ThangarajSatheeshS,
pubmed-author:VernetGuyG
|
pubmed:issnType |
Electronic
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
e12577
|
pubmed:meshHeading |
pubmed-meshheading:20830287-AIDS-Related Opportunistic Infections,
pubmed-meshheading:20830287-Adult,
pubmed-meshheading:20830287-Biological Markers,
pubmed-meshheading:20830287-Chemokine CCL8,
pubmed-meshheading:20830287-Chemokine CXCL10,
pubmed-meshheading:20830287-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:20830287-Female,
pubmed-meshheading:20830287-Humans,
pubmed-meshheading:20830287-Interleukin-2,
pubmed-meshheading:20830287-Male,
pubmed-meshheading:20830287-Prospective Studies,
pubmed-meshheading:20830287-Tuberculosis
|
pubmed:year |
2010
|
pubmed:articleTitle |
Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?
|
pubmed:affiliation |
Translational Research Unit, Department of Epidemiology and Preclinical Research, Lazzaro Spallanzani National Institute for Infectious Diseases (INMI), Rome, Italy. delia.goletti@inmi.it
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|